In contrast, in vivo PET imaging studies using various SV2A tracers have consistently reported decreased uptake in the hippocampus and temporal cortex of AD patients [3, 11, 22, 23, 29, 31, 69, 73], with conflicting results for the frontal cortex. The gene discussed is SV2A; the disease is Alzheimer disease.